sHLA-Ⅰ的研究进展

苗雅娇; 赵守松

sHLA-Ⅰ的研究进展

蚌埠医学院第一附属医院感染科

详细信息

中图分类号: R392
计量
- 文章访问数: 3190
- HTML全文浏览量: 14
- PDF下载量: 685
- 被引次数: 0
出版历程
- 出版日期: 2011-09-20

Advances in soluble HLA-Ⅰ

摘要

摘要: 人类白细胞抗原（HLA）-Ⅰ类抗原除了主要以跨膜蛋白形式存在于人体有核细胞膜之外,还有少量以可溶性状态存在于人类血液、尿液、淋巴液、乳汁等体液中,被称为可溶性人类白细胞抗原（sHLA）。sHLA-Ⅰ类抗原在肝炎、肝胆胰系统肿瘤及移植的患者血清中都有明显的变化。本文就sHLA-Ⅰ类抗原的结构及在临床疾病中的意义作一综述。
- HLA抗原 /
- 肝炎 /
- 消化系统肿瘤
Abstract: In addition to the main form of human HLA-Ⅰ, existing as a transmembrane protein in the nuclear membranes of human cells, there is a small amount of soluble form (sHLA-Ⅰ) found in many body fluids, including blood, urine, lymph, and breast milk, et al.Significant changes of sHLA-Ⅰ in serum are observed in individuals with hepatitis, hepatobiliary and pancreatic tumors, organ transplantation.In this paper, the structure of sHLA-Ⅰ and the significance of the protein in diseases are discussed.
- HLA agents /
- hepatitis /
- digestive system neoplasms

HTML全文

参考文献(28)

[1]Charlton RK, Zmijewski CM.Soluble HL-A7 antigen:Locali-zation in the beta-lipoprotein fraction of human serum[J].Science, 1970, 170 (958) :636-637.

[2]Van Rood JJ, Van Leeuwen A, Van Santen MC.Anti HL-A2 inhibitor in normal human serum[J].Nature, 1970, 226 (5243) :366-367.

[3]Mcnamara DM, Holubkov R, JanosSko K, et al.Pharmaco-genetic interactions between beta-blocker therapy and theangiotensin-converting enzyme deletion polymorphism inpatients with congestive heart failure[J].Circulation, 2001, 103 (12) :1644-1648.

[4]兰炯采.可溶性HLA-Ⅰ的检测用于对肾移植排斥反应的动态监控[J].中国免疫学杂志, 2004, 20:70-72.

[5]兰炯才, 吴涛, 周华友, 等.可溶性HLA-Ⅰ检测技术和贮存血中可溶性HLA-Ⅰ的浓度变化观察[J].中国实验血液学杂志, 2004, 12 (3) :363-367.

[6]张雄鹰, 吴延隽, 程红兵, 等.山西汉族可溶性HLA-Ⅰ类抗原检测[J].四川生理科学杂志, 2009, 31 (2) :72-73.

[7]夏荣, 邱慧颖, 曹琼, 等.HLA-G重链分子β2的体外表达及纯化研究[J].中国输血杂志, 2007, 20:70-72.

[8]Lajoie J, Loembe MM, Poudrier J, et al.Blood soluble humanleukocyte antigen G levels are associatedwith human immunod-eficiency virus type 1 infection in Beninese comercial sex work-ers[J].Hum lmmunol, 2010, 71 (2) :182-185.

[9]Murdaca G, ContiniP, SettiM, et al.Behavior of non-clas-sical soluble HLA class G antigens in human immunodeficien-cy virus 1-infected patients before and after HAART:com-parison with classical soluble HLA-A, -B, -C antigensand potential role in immune-reconstitution[J].Clin lmmu-nol, 2009, 133 (2) :238-244.

[10]Lajoie J, Fontaine J, Tremblay C, et al.Persistence of highlevels of blood soluble human leukocyte antigen-G is asso-ciated with rapid progression of HIV infection[J].AIDS, 2009, 23 (11) :1437-1440.

[11]Yan W, Lin A, Chen BG, et al.Induction of both membrane-bound and soluble HLA-G expression in active human cyto-megalovirus infection[J].Infect Dis, 2009, 200 (5) :820-826.

[12]黄文琪, 裴斌.慢性乙型肝炎治疗可溶性HLA-Ⅰ类分子含量的动态变化[J].检验医学与临床, 2004, 1 (1) :4-5.

[13]任添华, 张淑文.乙型肝炎患者血清sHLA-Ⅰ检测分析[J].临床荟萃, 2003, (18) 2:102-104.

[14]裴斌, 陈长荣, 黄文琪, 等.干扰素-α联合病毒唑治疗中慢性丙型肝炎可溶性HLA-Ⅰ类抗原的变化[J].中国医师杂志, 2006, 8 (7) :1000-1001.

[15]Wang PJ, Fu YM, Ding SX, et al.Elevation of plasma solubleHLA-G in patients with chronic hepatitis C virus (HCV) infection[J].Human Immunology, 2011, 72 (5) :406-411.

[16]Shimura T, Tsutsumi S, Hosouchi Y, et al.Clinical signifi-cance of soluble form of HLA classⅠmolecule in Japanesepatients with pancreatic cancer[J].Hum lmmunol, 2001, 62 (6) :615-619.

[17]Sch櫣tt P, Rebmann V, Brandhorst D, et al.The clinical sig-nificance of soluble human leukocyte antigen class-Ⅰ, IC-TP, and RANKL molecules in multiple myelomapatients[J].Hum lmmunol, 2008, 69 (2) :79-87.

[18]徐伟, 赵春亭, 苏湛, 等.恶性血液病患者血清sHLA-Ⅰ水平的变化及临川意义[J].山东医学, 2010, 50 (13) :16-18.

[19]Sch櫣tt P, Sch櫣tt B, Switala M, et al.Prognostic relevanceof soluble human leukocyte antigen-G and total human leu-kocyte antigen classⅠmolecules in lung cancer patients[J].Hum lmmunol, 2010, 71 (5) :489-495.

[20]Pegov RG, AliasovaAV, Novikov VV, et al.The serum levelsof asoluble form of HLA-Ⅰmolecules in patients with lungcancer[J].Klin Lab Diaqn, 2009, (2) :38-40.

[21]Zhu CB, Wang CX, Zhang X, et al.Serum sHLA-G levels:a useful indicator in distinguishing colorectal cancer from be-nign colorectal diseases[J].Int J Cancer, 2011, 128 (3) :617-622.

[22]Chen HX, Lin A, Shen CJ, et al.Upregulation of human leu-kocyte antigen-G expression and its clinical significance inductal breast cancer[J].Hum lmmunol, 2010, 71 (9) :892-889.

[23]Li BL, Lin A, Zhang XJ, et al.Characterization of HLA-Gexpression in renal cell carcinoma[J].Tissue Antigens, 2009, 74 (3) :213-221.

[24]李正原, 陈规划, 陆敏强.肝移植术后血清可溶性人类白细胞Ⅰ类抗原的动态观察[J].肝胆胰外科杂志, 2004, 16 (1) :35-37.

[25]Coupel S, Moreau A, Hamidou M, et al.Expression and re-lease of souble HLA-Ⅰis an immunoregulatory feature of endo-thelial cell actvation[J].Blood, 2007, 109 (7) :2506-2514.

[26]Rebmann V, Bartsch D, Wunsch A, et al.Soluble total hu-man leukocyte antigen classⅠand human leukocyte antigen-G molecules in kidney and kidney/pancreas transplantation[J].Hum lmmunol, 2009, 70 (12) :995-999.

[27]Bast櫣rk B, Karakayali F, Emiro gˇlu R, et al.Human leuko-cyte antigen-G, a new parameter in the follow-up of livertransplantation[J].Transplant Proc, 2006, 38 (2) :571-574.

[28]Zarkhin V, Talisetti A, Li L, et al.Expression of soluble HLA-G identifies favorable outcomes in liver transplant recipients[J].Transplantation, 2010, 90 (9) :1000-1005.

施引文献

资源附件(0)

访问统计